What is RxFunction?
Headquartered in Eden Prairie, Minnesota, RxFunction operates at the intersection of biomechanics and patient care. Since its inception in 2010, the company has dedicated its resources to designing and marketing sophisticated medical devices aimed at mitigating fall risks. Their core technology is engineered to restore balance and enhance mobility, directly addressing the needs of patients who face significant physical instability. By integrating advanced sensor technology with clinical insights, RxFunction provides a critical service that improves quality of life and reduces the healthcare burden associated with fall-related injuries. The company's market position is defined by its commitment to evidence-based design and its ability to scale specialized medical hardware within the competitive healthcare landscape.
How much funding has RxFunction raised?
RxFunction has raised a total of $11.6M across 3 funding rounds:
Private Equity
$4M
Series A
$7.5M
Debt
$150K
Private Equity (2017): $4M, investors not publicly disclosed
Series A (2018): $7.5M, investors not publicly disclosed
Debt (2020): $150K supported by PPP
Key Investors in RxFunction
PPP
Public-Private Partnership
Undisclosed Investor
An institutional partner participating in the company's private equity and series-level financing rounds to drive long-term value.
Undisclosed Investor
A strategic backer focused on the medical technology sector, providing the necessary capital to scale innovative patient mobility solutions.
What's next for RxFunction?
With the recent influx of capital, RxFunction is well-positioned to accelerate its product development roadmap and expand its commercial footprint. The current enterprise-level funding phase suggests a strategic pivot toward broader market penetration and the potential for clinical trial expansion. As the company matures, the focus will likely shift toward optimizing supply chain efficiencies and deepening its integration into hospital systems and rehabilitation centers. By leveraging this latest financing, RxFunction aims to solidify its intellectual property portfolio and enhance its technological capabilities, ensuring that its balance-restoration solutions remain at the forefront of the medical device industry. The firm's ability to navigate complex regulatory environments while maintaining a steady growth trajectory remains a key indicator of its long-term viability in the health-tech ecosystem.
See full RxFunction company page
